Leonard S. Paolillo's most recent trade in Impel Pharmaceuticals Inc was a trade of 50,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 14, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Impel Pharmaceuticals Inc | Leonard S. Paolillo | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Impel Pharmaceuticals Inc | Leonard S. Paolillo | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Impel Pharmaceuticals Inc | Leonard S. Paolillo | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) |